GSK plc
GSK plc's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link to the…
Insider buying and selling since 2009
GSK plc bought shares on the open market in 13 different years since 2009, and has not bought since 2023 across 9 companies. Sales in 4 of the 18 years since 2009.
GSK plc reported 27 open-market purchases and 13 sales since 2009; purchases in 13 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2023 | 1×1 trade | — |
| 2021 | 1×1 trade | 1×1 trade |
| 2020 | 1×1 trade | 4×4 trades |
| 2019 | 1×1 trade | — |
| 2018 | 1×1 trade | — |
| 2017 | 1×1 trade | — |
| 2016 | 1×1 trade | — |
| 2015 | 3×3 trades | — |
| 2014 | 4×4 trades | — |
| 2013 | 4×4 trades | — |
| 2012 | 4×4 trades | — |
| 2011 | 4×4 trades | 2×2 trades |
| 2010 | 1×1 trade | — |
| 2009 | — | 6×6 trades |
Insider at 9 companies
- Wave Life Sciences WVE2023 · 1 purchase, 0 sales
- Innoviva, Inc. INVA2010–2021 · 20 purchases, 1 sale
- Cvrx CVRX2021 · 1 purchase, 0 sales
- Bicycle Therapeutics BCYC2019–2020 · 1 purchase, 3 sales
- Nkarta NKTX2020 · 1 purchase, 0 sales
- Progyny, Inc. PGNY2020 · 0 purchases, 1 sale
- Spero Therapeutics SPRO2017–2018 · 2 purchases, 0 sales
- Crispr Therapeutics Ag CRSP2016 · 1 purchase, 0 sales
- Quest Diagnostics DGX2009–2011 · 0 purchases, 8 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about GSK plc's trades
Has GSK plc bought shares on the open market?
GSK plc bought shares on the open market in 13 different years since 2009, and has not bought since 2023 across 9 companies. Sales in 4 of the 18 years since 2009.
When did GSK plc last buy or sell shares?
In SEC filings since 2009: the latest open-market purchase is from 2023; the latest open-market sale is from 2021.
Which companies has GSK plc traded as an insider?
9 companies: Wave Life Sciences (WVE, 2023), Innoviva, Inc. (INVA, 2010–2021), Cvrx (CVRX, 2021), Bicycle Therapeutics (BCYC, 2019–2020), Nkarta (NKTX, 2020) and others.